NKTR: Nektar Therapeutics Company Short-Term Debt
The medical sector of Nektar Therapeutics (NKTR) is susceptible to global conflicts that hinder raw material logistics and international patent protection. This daily price chart reflects these complexities, with the debt ratio standing at 0.02. Nektar Therapeutics (NKTR) minimizes biotech risks by developing drugs to combat inflammation and cancer. To compete with industry behemoths and offset the cost of expensive trials, the business is reorganizing its scientific base and seeking strategic allies.
Metric breakdowns and analytics for Nektar Corp (NKTR)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Nektar Therapeutics|NKTR - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Nektar Therapeutics|NKTR - Company Total Debt|Debt to Book Capitalization Ratio Nektar Therapeutics Inc.|NKTR - Company Long-Term Liabilities|Company Current Liabilities Nektar Therapeutics|Quick Liquidity nektar.com
- net income and valuation multiples indicators:
Initial company analysis:NKTR - Nektar Therapeutics Inc.
Controlling issuer liquidity is critical for constructing a resilient portfolio. This metric aggregates all obligations maturing within one year to measure insolvency risk. For Nektar Therapeutics (NKTR), this indicator reflects financial stability while seeking partners for the commercialization of immunotherapy. The trend in total short-term debt allows for an assessment of management's margin of safety. A declining curve minimizes default risk but may signal a reduction in R&D investment.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|precigen.com - Company Short-Term Indebtedness|Company Short-Term Debts PHAR (Pharming Group)|Upstream Bio, Inc. (UPB) - Short-Term Debt|ZBIO - Company Short-Term Debt|IMNM (Immunome Bio) - Company Short-Term Indebtedness|GOSS: Company Short-Term Debts|Short-Term Debt kalvista.com (KALV)|Company Short-Term Debt Septerna|Company Short-Term Debts Pieris Pharma|Company Current Liabilities SVRA (Savara Corp)|Amount of Current Liabilities RIGL|Company Short-Term Debts ANAB (AnaptysBio, Inc.)|Company Short-Term Debts astriatx.com ATXS|ENGN - Company Short-Term Debt|Company Short-Term Loans and Borrowings RAPT (rapt.com)|JBIO (aerovatetx.com) - Company Current Liabilities|Aclaris Therapeutics, Inc - Company Short-Term Loans and Borrowings|Company Current Liabilities KYTX|TLSA (tizianalifesciences.com) - Amount of Current Liabilities|Company Short-Term Debts CABA|VTYX (Ventyx Biosciences Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts THTX (Theratechnologies Inc)|Avalo Therapeutics Inc (AVTX) - Short-Term Debt|ELDN - Company Short-Term Debt|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|CLYM: Company Short-Term Debts|zurabio.com (ZURA) - Company Short-Term Debts|Company Short-Term Debt aTyr|Adagene Corp - Current Liabilities|Company Short-Term Debts IMA|STTK - Short-Term Debt|Equillium - Company Current Liabilities|Company Short-Term Debts Connect Biopharma Holdings CNTB|IMUX: Company Current Liabilities|Atara Biotherapeutics - Amount of Current Liabilities|IFRX: Company Short-Term Debts|XFOR - Short-Term Debt Volume|ACET (Adicet Bio Inc.) - Company Short-Term Debts|Company Current Liabilities Celularity Corp (CELU)|Company Short-Term Debt INmune Bio Corp (INMB)|Short-Term Debt Volume Barinthus Biotherapeutics Corp|Company Short-Term Debt Kezar Life Sciences KZR|SABS: Company Short-Term Indebtedness|AKTX - Company Short-Term Debt|ENLV - Company Short-Term Debts|QTTB (q32bio.com) - Company Current Liabilities|GOVX: Amount of Current Liabilities|Company Short-Term Debt Edesa Biotech, Inc.|IBIO: Company Short-Term Loans and Borrowings|Company Short-Term Debt Carisma Therapeutics (CARM)|XTLB: Current Liabilities|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Loans and Borrowings HCWB|Aptevo - Company Short-Term Debts|AIM - Company Short-Term Debts|aditxt.com (ADTX) - Company Short-Term Debt|GRI Bio Inc - Company Short-Term Loans and Borrowings|Company Short-Term Debt XORTX|Company Current Liabilities Vyome Therapeutics (HIND)|Company Short-Term Debts REVB|Company Short-Term Debts indaptusrx.com (INDP)|Scinai Immunotherapeutics Ltd. - Company Current Liabilities|Company Short-Term Loans and Borrowings CALI|Affimed Therapeutics - Company Short-Term Debts|Short-Term Debt Volume Allakos Inc. ALLK|hookipapharma.com (HOOK) - Company Short-Term Debt|Company Current Liabilities IGM Biosciences|Company Short-Term Debt iTeos Therapeutics, Inc.|Company Current Liabilities Ocean Biomedical Inc (OCEA)|Company Current Liabilities TCBP (TC BioPharm (Holdings) PLC)|Company Short-Term Debts Third Harmonic Bio Inc (THRD)